SELLAS Life Sciences Group, Inc. Weighted Average Number of Shares Outstanding, Basic and Diluted
SELLAS Life Sciences Group, Inc. (SLS) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 14.88 million shares for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-13.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2021-05-13
- SELLAS Life Sciences Group, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-03-31 was 14.88M shares, a 133.37% increase year-over-year.
- SELLAS Life Sciences Group, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-12-31 was 10.38M shares, a 115.54% increase year-over-year.
- SELLAS Life Sciences Group, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-09-30 was 8.42M shares, a 96.60% increase year-over-year.
- SELLAS Life Sciences Group, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-06-30 was 6.72M shares, a 939.98% increase year-over-year.
- SELLAS Life Sciences Group, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 7.98M shares, a 211.76% increase from fiscal 2019.
- SELLAS Life Sciences Group, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 2.56M shares, a 878.33% increase from fiscal 2018.
- SELLAS Life Sciences Group, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 261.54K shares, a 88.82% decline from fiscal 2017.
- SELLAS Life Sciences Group, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2017 was 2.34M shares, a 147.03% increase from fiscal 2016.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2021-03-31 | 14.88M shares 10-Q · filed 2021-05-13 | 12.63M shares derived: average of 2 quarters · filed 2021-05-13 | 11.23M shares derived: average of 3 quarters · filed 2021-05-13 | 10.10M shares derived: average of 4 quarters · filed 2021-05-13 | ||||
| 2020-12-31 | 10.38M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-23 | 9.40M shares derived: average of 2 quarters · filed 2021-03-23 | 8.51M shares derived: average of 3 quarters · filed 2021-03-23 | 7.98M shares 10-K · filed 2021-03-23 | ||||
| 2020-09-30 | 8.42M shares 10-Q · filed 2020-11-13 | 7.57M shares derived: average of 2 quarters · filed 2020-11-13 | 7.17M shares 10-Q · filed 2020-11-13 | 6.58M shares derived: average of 4 quarters · filed 2021-05-13 | ||||
| 2020-06-30 | 6.72M shares 10-Q · filed 2020-08-13 | 6.55M shares 10-Q · filed 2020-08-13 | 5.97M shares derived: average of 3 quarters · filed 2021-05-13 | 5.55M shares derived: average of 4 quarters · filed 2021-05-13 | ||||
| 2020-03-31 | 6.37M shares 10-Q · filed 2021-05-13 | 5.60M shares derived: average of 2 quarters · filed 2021-05-13 | 5.16M shares derived: average of 3 quarters · filed 2021-05-13 | 4.03M shares derived: average of 4 quarters · filed 2021-05-13 | ||||
| 2019-12-31 | 4.82M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-23 | 4.55M shares derived: average of 2 quarters · filed 2021-03-23 | 3.25M shares derived: average of 3 quarters · filed 2021-03-23 | 2.56M shares 10-K · filed 2021-03-23 | ||||
| 2019-09-30 | 4.28M shares 10-Q · filed 2020-11-13 | 2.46M shares derived: average of 2 quarters · filed 2020-11-13 | 1.81M shares 10-Q · filed 2020-11-13 | 1.45M shares derived: average of 4 quarters · filed 2020-11-13 | ||||
| 2019-06-30 | 645.97K shares 10-Q · filed 2020-08-13 | 32.30M shares 10-Q · filed 2019-08-14 | 547.21K shares 10-Q · filed 2020-08-13 | 27.36M shares 10-Q · filed 2019-08-14 | 509.94K shares derived: average of 3 quarters · filed 2020-08-13 | 470.63K shares derived: average of 4 quarters · filed 2020-08-13 | ||
| 2019-03-31 | 447.36K shares 10-Q · filed 2020-05-14 | 22.37M shares 10-Q · filed 2019-05-15 | 441.93K shares derived: average of 2 quarters · filed 2020-05-14 | 412.19K shares derived: average of 3 quarters · filed 2020-05-14 | 2.00M shares derived: average of 4 quarters · filed 2020-05-14 | |||
| 2018-12-31 | 436.50K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | 394.61K shares derived: average of 2 quarters · filed 2020-03-13 | 2.52M shares derived: average of 3 quarters · filed 2020-03-13 | 261.54K shares 10-K · filed 2020-03-13 | 13.08M shares 10-K · filed 2019-03-22 | |||
| 2018-09-30 | 352.71K shares 10-Q · filed 2019-11-14 | 17.64M shares 10-Q · filed 2018-11-14 | 3.56M shares derived: average of 2 quarters · filed 2019-11-14 | 203.22K shares 10-Q · filed 2019-11-14 | 10.16M shares 10-Q · filed 2018-11-14 | 3.15M shares derived: average of 4 quarters · filed 2019-11-14 | ||
| 2018-06-30 | 6.77M shares 10-Q · filed 2019-08-14 | 6.39M shares 10-Q · filed 2019-08-14 | 4.08M shares derived: average of 3 quarters · filed 2019-08-14 | 3.55M shares derived: average of 4 quarters · filed 2019-08-14 | ||||
| 2018-03-31 | 5.95M shares 10-Q · filed 2019-05-15 | 2.73M shares derived: average of 2 quarters · filed 2019-05-15 | 2.47M shares derived: average of 3 quarters · filed 2019-05-15 | 2.18M shares derived: average of 4 quarters · filed 2019-05-15 | ||||
| 2017-12-31 | -491.58K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | 735.62K shares derived: average of 2 quarters · filed 2019-03-22 | 928.24K shares derived: average of 3 quarters · filed 2019-03-22 | 2.34M shares 10-K · filed 2019-03-22 | ||||
| 2017-09-30 | 1.96M shares 10-Q · filed 2018-11-14 | 1.64M shares derived: average of 2 quarters · filed 2018-11-14 | 3.28M shares 10-Q · filed 2018-11-14 | |||||
| 2017-06-30 | 1.31M shares 10-Q · filed 2018-08-14 | 1.29M shares 10-Q · filed 2018-08-14 | ||||||
| 2017-03-31 | 1.27M shares 10-Q · filed 2018-05-15 | |||||||
| 2016-12-31 | 947.40K shares 10-K · filed 2018-04-13 | 9.96M shares 10-K · filed 2017-03-15 | ||||||
| 2016-03-31 | 179.37M shares 10-Q · filed 2016-05-10 | -124.29M shares derived: average of 2 quarters · filed 2017-03-15 | -28.91M shares derived: average of 3 quarters · filed 2017-03-15 | 18.67M shares derived: average of 4 quarters · filed 2017-03-15 | ||||
| 2015-12-31 | -427.95M shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | -133.05M shares derived: average of 2 quarters · filed 2017-03-15 | -34.90M shares derived: average of 3 quarters · filed 2017-03-15 | 7.76M shares 10-K · filed 2017-03-15 | 155.26M shares 10-K · filed 2016-03-10 | |||
| 2015-09-30 | 161.86M shares 10-Q · filed 2015-11-09 | 161.62M shares derived: average of 2 quarters · filed 2015-11-09 | 153.00M shares 10-Q · filed 2015-11-09 | 32.47M shares derived: average of 4 quarters · filed 2017-03-15 | ||||
| 2015-06-30 | 161.38M shares 10-Q · filed 2015-08-06 | 148.65M shares 10-Q · filed 2015-08-06 | -10.66M shares derived: average of 3 quarters · filed 2017-03-15 | 21.76M shares derived: average of 4 quarters · filed 2017-03-15 | ||||
| 2015-03-31 | 136.05M shares 10-Q · filed 2016-05-10 | -96.69M shares derived: average of 2 quarters · filed 2017-03-15 | -24.78M shares derived: average of 3 quarters · filed 2017-03-15 | 10.94M shares derived: average of 4 quarters · filed 2017-03-15 | ||||
| 2014-12-31 | -329.43M shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | -105.19M shares derived: average of 2 quarters · filed 2017-03-15 | -30.77M shares derived: average of 3 quarters · filed 2017-03-15 | 5.97M shares 10-K · filed 2017-03-15 | 119.39M shares 10-K · filed 2015-03-05 | |||
| 2014-09-30 | 119.04M shares 10-Q · filed 2015-11-09 | 118.56M shares derived: average of 2 quarters · filed 2015-11-09 | 117.77M shares 10-Q · filed 2015-11-09 | 115.01M shares derived: average of 4 quarters · filed 2016-04-15 | ||||
| 2014-06-30 | 118.08M shares 10-Q · filed 2015-08-06 | 117.15M shares 10-Q · filed 2015-08-06 | 113.67M shares derived: average of 3 quarters · filed 2016-04-15 | 107.08M shares derived: average of 4 quarters · filed 2016-04-15 | ||||
| 2014-03-31 | 116.24M shares 10-Q · filed 2015-05-07 | 111.47M shares derived: average of 2 quarters · filed 2016-04-15 | 103.42M shares derived: average of 3 quarters · filed 2016-04-15 | 98.48M shares derived: average of 4 quarters · filed 2016-04-15 | ||||
| 2013-12-31 | 106.69M shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2016-04-15 | 97.00M shares derived: average of 2 quarters · filed 2016-04-15 | 92.56M shares derived: average of 3 quarters · filed 2016-04-15 | 90.18M shares 10-K/A · filed 2016-04-15 | ||||
| 2013-09-30 | 87.32M shares 10-Q · filed 2014-11-05 | 85.49M shares derived: average of 2 quarters · filed 2014-11-05 | 84.68M shares 10-Q · filed 2014-11-05 | 80.86M shares derived: average of 4 quarters · filed 2015-12-04 | ||||
| 2013-06-30 | 83.66M shares 10-Q · filed 2014-08-11 | 83.33M shares 10-Q · filed 2014-08-11 | 78.71M shares derived: average of 3 quarters · filed 2015-12-04 | 75.85M shares derived: average of 4 quarters · filed 2015-12-04 | ||||
| 2013-03-31 | 83.00M shares 10-Q · filed 2014-05-06 | 76.24M shares derived: average of 2 quarters · filed 2015-12-04 | 73.25M shares derived: average of 3 quarters · filed 2015-12-04 | 71.21M shares derived: average of 4 quarters · filed 2015-12-04 | ||||
| 2012-12-31 | 69.47M shares derived: 8-K 12 month − 10-Q/A 9 month · filed 2015-12-04 | 68.37M shares derived: average of 2 quarters · filed 2015-12-04 | 67.28M shares derived: average of 3 quarters · filed 2015-12-04 | 62.48M shares 8-K · filed 2015-12-04 | ||||
| 2012-09-30 | 67.27M shares 10-Q/A · filed 2013-11-07 | 67.27B shares 10-Q · filed 2012-11-13 | 66.19M shares derived: average of 2 quarters · filed 2013-11-07 | 60.15M shares 10-Q/A · filed 2013-11-07 | 60.15B shares 10-Q · filed 2012-11-13 | -25.19B shares derived: average of 4 quarters · filed 2014-03-17 | ||
| 2012-06-30 | 65.11M shares 10-Q · filed 2012-08-14 | 56.55M shares 10-Q · filed 2012-08-14 | -33.61B shares derived: average of 3 quarters · filed 2014-03-17 | -14.72B shares derived: average of 4 quarters · filed 2014-03-17 | ||||
| 2012-03-31 | 47.97M shares 10-Q · filed 2013-05-09 | -50.45B shares derived: average of 2 quarters · filed 2014-03-17 | -19.64B shares derived: average of 3 quarters · filed 2014-03-17 | -14.72B shares derived: average of 4 quarters · filed 2014-03-17 | ||||
| 2011-12-31 | -100.95B shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | -29.49B shares derived: average of 2 quarters · filed 2014-03-17 | -19.65B shares derived: average of 3 quarters · filed 2014-03-17 | 36.33M shares 10-K · filed 2014-03-17 | ||||
| 2011-09-30 | 41.97B shares 10-Q · filed 2012-11-13 | 21.00B shares derived: average of 2 quarters · filed 2012-11-13 | 33.70B shares 10-Q · filed 2012-11-13 | |||||
| 2011-06-30 | 38.57M shares 10-Q · filed 2012-08-14 | 29.49M shares 10-Q · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |